Mode
Text Size
Log in / Sign up
N/A N=102 Randomized Prevention

Leg Elevation to Prevent Hypotension During Labor

Hypotension · Labor Complication

Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Number of Patients With Maternal Hypotension Requiring Treatment — 6; 11; 48; 27 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Leg Elevation (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
TriHealth Inc.
Primary completion
May 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Patients With Maternal Hypotension Requiring Treatment
6; 11; 48; 27
PRIMARY
Number of Patients With Late or Prolonged Decelerations on the Fetal Heart Tracings
10; 12; 44; 26

Summary

When hypotension is related to epidural placement, this can occur within 15-60 minutes after placement. The purpose of this study is to build upon this preliminary work and to use a randomized controlled trial to examine the effectiveness of leg elevation in preventing hypotension among a larger sample of laboring women who receive an epidural analgesia. This study will use a randomized, non-blinded, controlled design with two arms: Arm 1: Patient will be put in a left tilt position with her hip on a wedge and both legs elevated on a peanut ball. She'll remain in this position for approximately 40 minutes. Arm 2: Patient will be put in a left tilt position with her hip on a wedge and no leg elevation. She'll remain in this position for approximately 40 minutes.

Eligibility Criteria

Inclusion Criteria

  • Laboring at Good Samaritan Hospital Labor & Delivery Unit
  • 37+ weeks gestation
  • Planned vaginal delivery
  • Planned epidural analgesia

Exclusion Criteria

  • Under 18 years old
  • Does not speak English
  • Unable to consent to involvement in the research study
  • Attended less than 3 prenatal care office visits
  • Diagnosed with fetal demise
  • Diagnosed with fetal anomalies
  • Contraindications to both legs being elevated (ex: fractured bones, lower limb amputation, etc.)
  • Contraindications to receiving 1L of IV fluids
  • Requiring IV hypertensive medications
  • Requiring IV magnesium
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05674838). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search